Volume 152, Issue 2, Pages (August 2017)

Slides:



Advertisements
Similar presentations
HYSTORY: The Registry was established in AIM OF THE REGISTRY: - understanding the pathogenesis of HUS/TTP - studying the genetic and biochemical.
Advertisements

Treatment Strategies for Carla M. Nester MD, MSA Assistant Professor Director, Pediatric Glomerular Disease Clinic University of Iowa 28 September, 2012.
BCSLS Hematology Telehealth Broadcast
Hemolytic Uremic Syndrome
Plasma Exchange for TAMOF Joseph A Carcillo MD University of Pittsburgh.
MLAB 1415: Hematology Keri Brophy-Martinez Hemolytic Anemia: Nonimmune Defects.
MLAB 1415: Hematology Keri Brophy-Martinez Chapter 18: Hemolytic Anemia: Nonimmune Defects.
DR AHMED SHAFI C.P MBBS.MD.(PATH). EX.PGI.CHANDIGARH PROFESSOR OF PATHOLOGY KMC. ANJARAKANDY.
Nursing Management: Hematologic Problems Chapter 31 Overview Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier Inc.
MAHA: diagnosis and management
A 23 year old Caucasian male presented with shortness of breath, hypertension, bloody sputum, and a history of drug abuse (confirmed by urinalysis). He.
Atypical HUS – Updates 2016 Christoph Licht The Hospital for Sick Children Division of Nephrology aHUS RareConnect Webinar.
Disseminated Intravascular Coagulation
Secondary Kwashiorkor: A Rare Complication of Gastric Bypass Surgery
APTT, activated partial thromboplastin time; CAD, coronary artery disease; DIC, disseminated intravascular coagulation; GI, gastrointestinal; INR, international.
Diagnostic approach: anemia
Platelets disorders.
Antibodies to Heparin–Platelet Factor 4 Complex: Pathogenesis, Epidemiology, and Management of Heparin-Induced Thrombocytopenia in Hemodialysis  Andrew.
Hemolytic uremic syndrome
Assessing the Evidence and Implications for Clinical Practice
David A. Terrero Salcedo, MD, Maria A
Florid erythrophagocytosis by neutrophils in peripheral blood
Approach to Thrombocytopenia
Discounted Coagulation Profiles Clinical Laboratories.
Thrombotic Microangiopathy Care Pathway: A Consensus Statement for the Mayo Clinic Complement Alternative Pathway-Thrombotic Microangiopathy (CAP-TMA)
Secondary Kwashiorkor: A Rare Complication of Gastric Bypass Surgery
Volume 89, Issue 3, Pages (March 2016)
Volume 152, Issue 5, Pages (November 2017)
Drug-Induced Liver Injury
Hepatitis in the traveller
Complement and Haemolytic Uraemic Syndrome – ESPN 2008
The Hematologic System as a Marker of Organ Dysfunction in Sepsis
Drug-Induced Liver Injury
by Ali Imran Amjad, and Rahul A. Parikh
Disseminated intravascular coagulation (DIC) + Thrombotic microangiopathies (TTP+HUS) Ali Al Khader, M.D. Faculty of Medicine Al-Balqa’ Applied University.
Complement Regulatory Genetic Mutations in the Setting of Autoimmune Thrombotic Thrombocytopenic Purpura: A Case Series  Shebli Atrash, MD, Appalanaidu.
Managing Nontraumatic Acute Back Pain
Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3.
A 61-Year-Old Man With Membranoproliferative Glomerulonephritis
Fibrinogen Levels After Cardiac Surgical Procedures: Association With Postoperative Bleeding, Trigger Values, and Target Values  Marco Ranucci, MD, Valeria.
Antibodies to Heparin–Platelet Factor 4 Complex: Pathogenesis, Epidemiology, and Management of Heparin-Induced Thrombocytopenia in Hemodialysis  Andrew.
IV Immunoglobulin for Autoimmune Heparin-Induced Thrombocytopenia
Tait D. Shanafelt, MD, Timothy G. Call, MD  Mayo Clinic Proceedings 
D.X. Li  Clinical Microbiology and Infection 
Discontinuation of Eculizumab in a Patient With Atypical Hemolytic Uremic Syndrome Due to a Mutation in CFH  Sandra Habbig, MD, Carsten Bergmann, MD,
Alicia K. Morgans, MD, Ran Reshef, MD, Donald E. Tsai, MD, PhD 
How I treat catastrophic thrombotic syndromes
Two cases of myomectomy complicated by intravascular hemolysis and renal failure: disseminated intravascular coagulation or hemolytic uremic syndrome? 
Recent outbreak of hemolytic uremic syndrome in Germany
Imaging for the Management of Community-Acquired Pneumonia
Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial  Fadi Fakhouri, MD,
Piero Ruggenenti, Marina Noris, Giuseppe Remuzzi  Kidney International 
Volume 70, Issue 3, Pages (August 2006)
Treating Atypical Hemolytic Uremic Syndrome A Case Discussion
The molecular biology of thrombotic microangiopathy
Palliative Care, Spiritual Care, and Clinical Ethics
Kidney Transplantation in Patients With Atypical Hemolytic Uremic Syndrome: A Therapeutic Dilemma (or Not)?  Marina Noris, PhD, Piero Ruggenenti, MD,
Combined use of extracorporeal membrane oxygenation and activated protein C for severe acute respiratory distress syndrome and septic shock  Yoan Lamarche,
Hassanali H. Sewani, MD, Jeffrey T. Rabatin, MD 
Volume 66, Issue 3, Pages (September 2004)
Increased Urinary Albumin Excretion Following Recovery From Thrombotic Thrombocytopenic Purpura Due to Acquired ADAMTS13 Deficiency  Dustin J. Little,
Anemia in Adults: A Contemporary Approach to Diagnosis
Journal of Obstetrics and Gynaecology Canada
HUS and atypical HUS by T. Sakari Jokiranta Blood
A previously healthy 43-year-old man with chronic alcoholism presented to a rural medical center with a 2-week history of confusion, fever, dyspnea, dizziness,
Managing the Complications of Cirrhosis
Schematic model of the role of complement activation, cell damage, and thrombosis in various severe diseases or conditions with major thrombotic problems.
A diagnostic algorithm for the investigation and management of a patient presenting with thrombotic microangiopathy. A diagnostic algorithm for the investigation.
Thrombocytopenia in pregnancy
Thrombotic microangiopathies are classified into: Inherited or acquired primary; secondary; or infection associated TMAs. Current classifications define.
Presentation transcript:

Volume 152, Issue 2, Pages 424-434 (August 2017) Expert Statements on the Standard of Care in Critically Ill Adult Patients With Atypical Hemolytic Uremic Syndrome  Elie Azoulay, MD, PhD, Paul Knoebl, MD, José Garnacho-Montero, MD, PhD, Katerina Rusinova, MD, PhD, Gennadii Galstian, MD, PhD, Philippe Eggimann, MD, PhD, Fekri Abroug, MD, PhD, Dominique Benoit, MD, PhD, Michael von Bergwelt-Baildon, MD, PhD, Julia Wendon, MD, Marie Scully, MD  CHEST  Volume 152, Issue 2, Pages 424-434 (August 2017) DOI: 10.1016/j.chest.2017.03.055 Copyright © 2017 The Authors Terms and Conditions

Figure 1 Pathophysiology of TMAs.1 ADAMTS13 = a disintegrin and metalloproteinase with thrombospondin motifs 13; aHUS = atypical hemolytic uremic syndrome; C3 = complement component 3; CMV = cytomegalovirus; EBV = Epstein-Barr virus; FB = complement factor B; FH = complement factor H; FI = complement factor I; HELLP = hemolysis, elevated liver enzymes, low platelet count; HUS = hemolytic uremic syndrome; inc. = including; MCP = membrane cofactor protein; STEC = Shiga toxin-producing Escherichia coli; STEC-HUS = Shiga toxin-associated hemolytic uremic syndrome; THBD = thrombomodulin; TMA = thrombotic microangiopathy; TTP = thrombotic thrombocytopenic purpura. CHEST 2017 152, 424-434DOI: (10.1016/j.chest.2017.03.055) Copyright © 2017 The Authors Terms and Conditions

Figure 2 Algorithm for the differential diagnosis of aHUS in the ICU.1,12,14,21-24 *If two categories of clinical findings are present (organ damage and/or thrombocytopenia and/or microangiopathic hemolysis), repeat tests after 24 hours. If three categories of clinical findings are present, move to TMA diagnosis confirmation. **Includes acute viremia (CMV, HIV, or EBV), pregnancy-associated complications (HELLP or preeclampsia), malignant hypertension, catastrophic antiphospholipid antibody syndrome, and severe systemic autoimmune diseases. This list is not exhaustive. ADP = adenosine diphosphate; aPTT= activated partial thromboplastin time; CNS = central nervous system; DIC = disseminated intravascular coagulation; EHEC = enterohemorrhagic Escherichia coli; GI = gastrointestinal; GP = glycoprotein; Hb = hemoglobin; LDH, = lactate dehydrogenase; N.V. = normal value; PLT = platelet; sCr = serum creatinine. See Figure 1 legend for expansion of other abbreviations. CHEST 2017 152, 424-434DOI: (10.1016/j.chest.2017.03.055) Copyright © 2017 The Authors Terms and Conditions

Figure 3 Frequency of organ involvement in atypical hemolytic uremic syndrome.9 See Figure 2 legend for expansion of abbreviations. CHEST 2017 152, 424-434DOI: (10.1016/j.chest.2017.03.055) Copyright © 2017 The Authors Terms and Conditions